Company Profile

AstraZeneca plc (NYSE: AZN)
Pricing data not available
Detailed Quote
Open: $ n/a   Volume: n/a
High: $ n/a   Yield(%) n/a
Low: $ n/a   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -4.31
% Price Change (last 13 weeks): 0.82
% Price Change (last 26 weeks): -5.54
% Price Change (last 52 weeks): -4.85
% Price Change (year to date): -4.78
Management Effectiveness
Return on Equity (%): 15.63
Return on Assets (%): 6.03
Return on Invested Capital (%): 5.93
Profitability
Gross Profit Margin (%): 73.95
Net Profit Margin (%): 13.00
Operating Profit Margin (%): 20.54
Price & Volume
50-day Moving Average: $66.21
200-day Moving Average: $67.83
Avg. Daily Vol. (last 50 days): 6,760,913
Avg. Daily Vol. (last 200 days): 5,553,071
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AstraZeneca plc
Cambridge Biomedical Campus 1 Francis Crick Avenue
Cambridge CA CB2 0AA

Phone: 44.20.3749.5000
Fax: n/a
http://www.astrazeneca.co.uk
Per Share Data
Earnings (1year) ($): 1.92
Annual Dividend ($): 1.42
Current P/E Ratio (ttm): n/a
Book Value ($): 12.63
Cash Flow ($): 3.51
Valuation Ratios
Price/Earnings (x): 33.36
Price/Sales (x): 4.59
Price/Book (x): 5.33
Price/Cash Flow (x): 19.79
Financial Strength
Quick Ratio (x): 0.64
Current Ratio (x): 0.82
LT Debt/Equity (x): 59.33
Total Debt/Equity (x): 73.12



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.